Elite Pharmaceuticals, Inc. (ELTP)
0.2511
-0.01
(-2.33%)
USD |
OTCM |
Sep 10, 16:00
Elite Pharmaceuticals Gross Profit (TTM) : 59.79M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 59.79M |
| March 31, 2026 | 73.48M |
| December 31, 2025 | 69.96M |
| September 30, 2025 | 63.08M |
| June 30, 2025 | 57.18M |
| March 31, 2025 | 38.40M |
| December 31, 2024 | 29.25M |
| September 30, 2024 | 30.26M |
| June 30, 2024 | 28.60M |
| March 31, 2024 | 24.98M |
| December 31, 2023 | 20.35M |
| September 30, 2023 | 18.26M |
| June 30, 2023 | 15.64M |
| March 31, 2023 | 14.92M |
| December 31, 2022 | 14.94M |
| September 30, 2022 | 14.06M |
| June 30, 2022 | 14.02M |
| March 31, 2022 | 13.56M |
| December 31, 2021 | 11.97M |
| September 30, 2021 | 11.33M |
| June 30, 2021 | 11.15M |
| March 31, 2021 | 10.55M |
| December 31, 2020 | 11.14M |
| September 30, 2020 | 10.64M |
| June 30, 2020 | 8.347M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.670M |
| December 31, 2019 | 4.755M |
| September 30, 2019 | 2.788M |
| June 30, 2019 | 2.245M |
| March 31, 2019 | 1.661M |
| December 31, 2018 | 1.800M |
| September 30, 2018 | 2.306M |
| June 30, 2018 | 2.854M |
| March 31, 2018 | 3.147M |
| December 31, 2017 | 3.711M |
| September 30, 2017 | 3.185M |
| June 30, 2017 | 2.998M |
| March 31, 2017 | 3.418M |
| December 31, 2016 | 6.483M |
| September 30, 2016 | 7.091M |
| June 30, 2016 | 7.395M |
| March 31, 2016 | 7.102M |
| December 31, 2015 | 3.448M |
| September 30, 2015 | 2.707M |
| June 30, 2015 | 1.887M |
| March 31, 2015 | 1.318M |
| December 31, 2014 | 0.9692M |
| September 30, 2014 | 1.091M |
| June 30, 2014 | 1.252M |
| March 31, 2014 | 0.993M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Nektar Therapeutics | 53.90M |
| Daré Bioscience, Inc. | -1.748M |
| Eton Pharmaceuticals, Inc. | 61.10M |
| ANI Pharmaceuticals, Inc. | 505.18M |
| Corcept Therapeutics, Inc. | 816.73M |